Accessibility Menu
Carl Zeiss Meditec Ag logo

Carl Zeiss Meditec Ag(OTC) CZMWY

Market Cap$3.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+341%
5 Year-82%
1 Year-23%
1 Month+4%
$37.33
-1.66%
-0.63Today
Carl Zeiss Meditec Ag last closing stock price
MetricPriceDate
Last closeUSD 37.962026-09-02
Carl Zeiss Meditec Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.17%USD 36.442026-08-26
1 month+4.09%USD 36.472026-08-03
3 month+23.01%USD 30.862026-06-04
Year to date-17.1%USD 45.792025-12-31
1 year-22.81%USD 49.182025-09-02
3 year-59.85%USD 94.552023-09-01
5 year-82.25%USD 213.842021-09-03
Since inception+340.98%USD 8.612008-12-12

Carl Zeiss Meditec Ag Financials at a Glance

Market Cap

$3.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€2.66B

Net Income (TTM)

€116.81M

EPS (TTM)

$1.25

P/E Ratio

30.37

Dividend

$0.63

Beta (Volatility)

1.05 (Average)

Price

$37.33

Volume

3,335

Open

$38.05

Previous Close

$37.33

Daily Range

$37.33 - $38.16

52-Week Range

$26.65 - $55.94

Estimated Earnings Date

Dec 10, 2026

CZMWY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Carl Zeiss Meditec Ag

Carl Zeiss Meditec AG is a leading global medical technology company headquartered in Jena, Germany. The firm specializes in ophthalmic devices and microsurgery, providing innovative solutions for healthcare professionals worldwide.

Products and Services
  • Ophthalmic devices for cataract, retinal, and refractive surgeries
  • Advanced visualization tools for microsurgery across various medical fields
  • Comprehensive solutions for healthcare institutions and professionals
Growth Outlook
  • Revenue of €562.7 million in Q3 2026, indicating strong demand
  • Net income of €55.03 million in Q3 2026, showcasing profitability
  • Consistent investment in R&D, with €78.94 million spent in Q3 2026
Financial Highlights
  • Trailing twelve-month revenue of €2.5 billion, reflecting robust growth
  • Net profit margin of 4.4% for the trailing twelve months, indicating efficiency
  • Dividend yield of 1.71%, providing a return to shareholders
Carl Zeiss Meditec AG operates in a dynamic healthcare sector, focusing on innovative technologies that enhance surgical outcomes and patient care. The company's commitment to research and development positions it well for future growth, as evidenced by its recent financial performance. The strong revenue figures and profitability metrics suggest a solid foundation for potential investors. With a diverse product portfolio and a global presence, Carl Zeiss Meditec AG is poised to capitalize on the increasing demand for advanced medical technologies.
AI Generated • Aug 30, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

5,784

CEO

Maximilian Foerst

Website

www.zeiss.de

Headquarters

Jena, TH 07745, DE

CZMWY Financials

Key Financial Metrics (TTM)

Gross Margin

51.04%

Operating Margin

6.42%

Net Income Margin

4.40%

Return on Equity

5.52%

Return on Capital

8.53%

Return on Assets

0.00%

Earnings Yield

3.29%

Dividend Yield

1.66%

Payout Ratio

41.29%

Stock Overview

Market Cap

$3.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

87.54M

Volume

3.33K

Avg. Volume

2.84K

Financials (TTM)

Gross Profit

€1.64B

Operating Income

€169.25M

EBITDA

€409.69M

Operating Cash Flow

€298.89M

Capital Expenditure

-€29.19M

Free Cash Flow

€269.59M

Cash & ST Invst.

€23.90M

Total Debt

€0.00

Carl Zeiss Meditec Ag Performance Analysis

Carl Zeiss Meditec Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-09-30EUR 2,057,763,2554.6%
20232023-09-30EUR 2,226,938,0108.2%
20242024-09-30EUR 2,239,604,4120.6%
20252025-09-30EUR 2,459,407,1699.8%
Carl Zeiss Meditec Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-3014.2%
Q12025-12-31-25.6%
Q22026-03-31115.1%
Q32026-06-30-44.0%
Carl Zeiss Meditec Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-09-30EUR 3.5512.6%
20232023-09-30EUR 3.46-2.6%
20242024-09-30EUR 2.18-37.0%
20252025-09-30EUR 1.78-18.3%
Carl Zeiss Meditec Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42025-09-30172.7%
Q12025-12-31-106.7%
Q22026-03-31383.3%
Q32026-06-30276.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

€562.72M

+2.4%

Gross Profit

€302.28M

+4.3%

Gross Margin

53.72%

N/A

Market Cap

$3.32BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$574.49K

N/A

Employees

5,784

N/A

Net Income

€55.03M

+93.9%

EBITDA

€74.87M

+31.2%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

€23.90M

-10.0%

Total Debt

€0.00

N/A

Accounts Receivable

€0.00

N/A

Inventory

€0.00

N/A

Long Term Debt

€0.00

N/A

Short Term Debt

€0.00

N/A

Return on Assets

0.00%

N/A

Return on Invested Capital

0.00%

N/A

Free Cash Flow

€0.00

-100.0%

Operating Cash Flow

€0.00

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANSLFAnsell Limited
$21.64+0.00%
SNPHFSanten Pharmaceutical Co., Ltd.
$13.05+0.00%
FLMNFFielmann AG
$50.75+0.00%
BUHPFBumrungrad Hospital Public Company Limited
$6.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$10.38+0.11%
NVDANvidia
$228.45+0.02%
SPCXSpace Exploration Technologies
$149.74+0.06%
BITOProShares Trust - ProShares Bitcoin ETF
$11.01+0.06%

Questions About CZMWY

What is the current price of Carl Zeiss Meditec Ag?

Carl Zeiss Meditec Ag is trading at $37.33 per share.

What is the 52-week range for Carl Zeiss Meditec Ag?

Over the past 52 weeks, Carl Zeiss Meditec Ag has traded between $26.65 and $55.94.

How much debt does Carl Zeiss Meditec Ag have?

As of the most recent reporting period, Carl Zeiss Meditec Ag reported total debt of €713.66M.

How much cash does Carl Zeiss Meditec Ag have on hand?

Carl Zeiss Meditec Ag reported €32.04M in cash and cash equivalents in its most recent financial results.

What is Carl Zeiss Meditec Ag’s dividend yield?

Carl Zeiss Meditec Ag currently has a dividend yield of 1.66%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services